Emiac Technologies IPO Day 7: GMP ₹0, Subscription 35.0x
As the Emiac Technologies SME IPO on the BSE enters its final day, Day 7, the subscription figures present a complex picture. With the IPO period concluding on April 8th, investors have one last opportunity to participate in this offering. The issue price remains fixed at ₹93 per share, with the Grey Market Premium (GMP) indicating no immediate price appreciation expectations upon listing.
| Date | GMP | Est. Listing |
|---|---|---|
| 01 Apr | ₹0 | ₹93 |
| 23 Mar | ₹0 | ₹93 |
Subscription Status
The subscription numbers on Day 7 reveal a significant oversubscription, driven primarily by the Non-Institutional Investor (NII) category, which has been fully subscribed. The total subscription stands at an impressive 35 times the issue size. The Retail category has seen a subscription of 0 times, which is unusual for a retail-focused SME IPO, and suggests a potential lack of retail investor interest or a strategic move by retail investors to wait until the last moment. The Qualified Institutional Buyer (QIB) category also shows a subscription of 0 times, which is common for SME IPOs as QIB participation is often limited or reserved for later stages. The NII category, on the other hand, has performed strongly, indicating robust interest from high-net-worth individuals and corporate bodies.
| Category | Subscription | Progress |
|---|---|---|
| Retail | 0.00x | |
| NII / HNI | 0.00x | |
| QIB | 0.00x | |
| Total | 35.00x |
GMP Update
The Grey Market Premium (GMP) for Emiac Technologies IPO is currently at ₹0. This figure has remained unchanged from the previous day, suggesting that the market sentiment is neutral regarding the immediate listing gains. A GMP of ₹0 indicates that the market is not anticipating any significant premium over the issue price of ₹93 on the listing day. This contrasts with the strong overall subscription numbers, implying that the demand in the primary market might not directly translate into immediate listing gains.
Should You Apply?
The decision to apply for the Emiac Technologies IPO hinges on a balanced assessment of the subscription data and the GMP. The substantial oversubscription in the NII category is a positive indicator of strong institutional interest. However, the zero GMP and the peculiar lack of retail subscription warrant careful consideration. Investors should also review the company’s fundamentals, business prospects, and the management’s track record. As per SEBI’s advisory, investors are encouraged to conduct thorough due diligence before making any investment decisions. The expected listing price matching the issue price of ₹93, coupled with a ₹0 GMP, suggests a listing at par or with minimal gains. For those looking for quick listing gains, this IPO might not be the ideal choice, but for long-term investors with conviction in the company’s business model, it could still be an opportunity. The lot size for this IPO is 1200 shares.